Lyell Immunopharma shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Lyell Immunopharma
Tip: Access up to 7 years of quarterly data
All positions including Lyell Immunopharma held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lyell Immunopharma by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $10M | 7.4M | 1.38 |
| 2024-06-30 | $11M | 7.9M | 1.45 |
| 2024-03-31 | $15M | 6.7M | 2.23 |
| 2023-12-31 | $13M | 6.6M | 1.94 |
| 2023-09-30 | $9.8M | 6.7M | 1.47 |
| 2023-06-30 | $26M | 8.2M | 3.18 |
| 2023-03-31 | $9.4M | 4.0M | 2.36 |
| 2022-12-31 | $13M | 3.7M | 3.47 |
| 2022-03-31 | $28M | 5.5M | 5.05 |
| 2021-12-31 | $40M | 5.1M | 7.74 |
| 2021-09-30 | $54M | 3.7M | 14.80 |
| 2021-06-30 | $41M | 2.5M | 16.24 |